Merck KGaA (MKGAF) Stock Price, News & Analysis

Company Overview

Merck KGaA, headquartered in Darmstadt, Germany, is one of the world’s oldest chemical and pharmaceutical companies, tracing its origins back to 1668. Over its long history, the company has grown into a global science and technology leader, operating in more than 60 countries and employing over 58,000 people. Merck KGaA is publicly traded in Germany and its American depositary receipts trade on the OTCMKTS under the ticker MKGAF.

In its Life Science segment, Merck KGaA provides innovative tools, services and technologies that support research, development and production in the biopharmaceutical and biotechnology industries. Flagship brands such as MilliporeSigma offer critical reagents, laboratory filtration systems and process solutions that help researchers and manufacturers advance from early-stage discovery through to commercial-scale production.

The company’s Healthcare division focuses on prescription medicines in areas including oncology, immunology, neurology and fertility. Merck KGaA has developed therapies targeting multiple sclerosis, oncology immunotherapeutics and hormone treatments for reproductive health. It also invests in digital health initiatives and partnerships to enhance patient care and streamline clinical development processes.

In its Performance Materials arm, Merck KGaA delivers specialty chemicals and materials for high-tech applications, including liquid crystals for advanced displays, semiconductor deposition materials and photoresists. These technologies serve customers across electronics, automotive and information technology industries worldwide. Since May 2021, the company has been led by Chairwoman and CEO Belén Garijo, who oversees strategic growth and innovation initiatives across all business areas.

Key Stats

• Today's Range: $123.63 to $128.63
• 50-Day Range: $119.00 to $137.00
• 52-Week Range: $118.05 to $197.10
• Volume: 615 shs
• Average Volume: 1,016 shs
• Market Capitalization: $16.62 billion
• P/E Ratio: 19.63
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Strong Buy

Merck KGaA Stock Analysis - MarketRank™

Merck KGaA scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Merck KGaA.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 8.21%

Earnings Growth

Earnings for Merck KGaA are expected to grow by 8.21% in the coming year, from $9.75 to $10.55 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Merck KGaA is 19.64, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 269.24.

Price to Earnings Ratio vs. Sector

The P/E ratio of Merck KGaA is 19.64, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 82.63.

Price to Book Value per Share Ratio

Merck KGaA has a P/B Ratio of 0.61. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.30% of the outstanding shares of Merck KGaA have been sold short.

Short Interest Ratio / Days to Cover

Merck KGaA has a short interest ratio ("days to cover") of 143, which indicates bearish sentiment.

Change versus previous month

Short interest in Merck KGaA has recently decreased by 24.43%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Merck KGaA does not currently pay a dividend.

Dividend Growth

Merck KGaA does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.30% of the outstanding shares of Merck KGaA have been sold short.

Short Interest Ratio / Days to Cover

Merck KGaA has a short interest ratio ("days to cover") of 143, which indicates bearish sentiment.

Change versus previous month

Short interest in Merck KGaA has recently decreased by 24.43%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Merck KGaA this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Merck KGaA insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 0.10% of the stock of Merck KGaA is held by institutions.

MKGAF Stock Analysis - Frequently Asked Questions

How have MKGAF shares performed this year?

Merck KGaA's stock was trading at $151.56 on January 1st, 2025. Since then, MKGAF stock has decreased by 15.1% and is now trading at $128.6250.

How do I buy shares of Merck KGaA?

Shares of MKGAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 9/02/2025
• Next Earnings (Estimated): 11/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MKGAF
• CIK: N/A
• Web: www.merckgroup.com
• Phone: 496151720
• Fax: 49-61-5172-2000
• Employees: 62,908
• Year Founded: 1891

Profitability

• EPS (Trailing Twelve Months): $6.81
• Trailing P/E Ratio: 18.89
• Forward P/E Ratio: 12.69
• P/E Growth: N/A
• Net Income: $3.06 billion
• Net Margins: 12.60%
• Pretax Margin: 15.64%
• Return on Equity: 10.17%
• Return on Assets: 5.74%

Debt

• Debt-to-Equity Ratio: 0.27
• Current Ratio: 1.31
• Quick Ratio: 0.84

Sales & Book Value

• Annual Sales: $22.72 billion
• Price / Sales: 0.70
• Cash Flow: $37.27 per share
• Price / Cash Flow: 3.32
• Book Value: $212.00 per share
• Price / Book: 0.58

Miscellaneous

• Outstanding Shares: 129,240,000
• Free Float: N/A
• Market Cap: $15.99 billion
• Optionable: Not Optionable
• Beta: 0.96